Arrivent Biopharma Inc (AVBP)

SG&A Expense Growth

21.87%

Quarterly · Period ending:

AVBP logo

AVBP SG&A Expense Growth

Latest reported21.87%
AVBP Quarterly SG&A Growth (QoQ) (0.00% → 21.87%)
High-resolution chart · PNG

AVBP sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
21.8743%
27.7677%
8.1151%
4.1674%
7.66%
54.7995%
-14.527%
5.7413%
5.9476%
19.0154%
27.5862%
9.434%
14.9793%
7.8552%
6.9089%
11.9707%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.